Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Rowe

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Science Signaling|July 26, 2018
Quantitative analysis of competitive cytokine signaling predicts tissue thresholds for the propagation of macrophage activationJames Bagnall, Christopher Boddington, Hazel England, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 8, 2024
Lenacapavir Exhibits Atropisomerism-Mechanistic Pharmacokinetics and Disposition Studies of Lenacapavir Reveal Intestinal Excretion as a Major Clearance PathwayJim Zheng, Bing Lu, Gavin Carr, et al.
Water Research|November 5, 2023
Utility of wastewater genomic surveillance compared to clinical surveillance to track the spread of the SARS-CoV-2 Omicron variant across EnglandFranziska S Brunner, Alexander Payne, Edward Cairns, et al.
Microbial Genomics|April 19, 2023
Evaluation of variant calling algorithms for wastewater-based epidemiology using mixed populations of SARS-CoV-2 variants in synthetic and wastewater samplesIrene Bassano, Vinoy K Ramachandran, Mohammad S Khalifa, et al.
Hepatology (Baltimore, Md.)|April 5, 2020
Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis BStephane Daffis, Scott Balsitis, Jason Chamberlain, et al.
Metabolic Engineering|April 27, 2020
Rapid prototyping of microbial production strains for the biomanufacture of potential materials monomersChristopher J Robinson, Pablo Carbonell, Adrian J Jervis, et al.
Nature|December 7, 2021
Long-acting capsid inhibitor protects macaques from repeat SHIV challengesSamuel J Vidal, Elena Bekerman, Derek Hansen, et al.
Nature Cancer|February 5, 2022
A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneityKathryn L Simpson, Ruth Stoney, Kristopher K Frese, et al.
Ebiomedicine|August 25, 2023
Long-acting lenacapavir protects macaques against intravenous challenge with simian-tropic HIVAdrienne E Swanstrom, Robert J Gorelick, Jorden L Welker, et al.
Journal of Medicinal Chemistry|October 1, 2025
Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure ProphylaxisEda Canales, Winston Tse, Scott D Schroeder, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Science Signaling|July 26, 2018
Quantitative analysis of competitive cytokine signaling predicts tissue thresholds for the propagation of macrophage activationJames Bagnall, Christopher Boddington, Hazel England, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 8, 2024
Lenacapavir Exhibits Atropisomerism-Mechanistic Pharmacokinetics and Disposition Studies of Lenacapavir Reveal Intestinal Excretion as a Major Clearance PathwayJim Zheng, Bing Lu, Gavin Carr, et al.
Water Research|November 5, 2023
Utility of wastewater genomic surveillance compared to clinical surveillance to track the spread of the SARS-CoV-2 Omicron variant across EnglandFranziska S Brunner, Alexander Payne, Edward Cairns, et al.
Microbial Genomics|April 19, 2023
Evaluation of variant calling algorithms for wastewater-based epidemiology using mixed populations of SARS-CoV-2 variants in synthetic and wastewater samplesIrene Bassano, Vinoy K Ramachandran, Mohammad S Khalifa, et al.
Hepatology (Baltimore, Md.)|April 5, 2020
Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis BStephane Daffis, Scott Balsitis, Jason Chamberlain, et al.
Metabolic Engineering|April 27, 2020
Rapid prototyping of microbial production strains for the biomanufacture of potential materials monomersChristopher J Robinson, Pablo Carbonell, Adrian J Jervis, et al.
Nature|December 7, 2021
Long-acting capsid inhibitor protects macaques from repeat SHIV challengesSamuel J Vidal, Elena Bekerman, Derek Hansen, et al.
Nature Cancer|February 5, 2022
A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneityKathryn L Simpson, Ruth Stoney, Kristopher K Frese, et al.
Ebiomedicine|August 25, 2023
Long-acting lenacapavir protects macaques against intravenous challenge with simian-tropic HIVAdrienne E Swanstrom, Robert J Gorelick, Jorden L Welker, et al.
Journal of Medicinal Chemistry|October 1, 2025
Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure ProphylaxisEda Canales, Winston Tse, Scott D Schroeder, et al.
Pageof 6